Biotech entity
fda-approval is the sole category represented across all 1 tracked stories. Department of the Interior is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Kristen Boyles, all published on July 20, 2026.
Last mentioned: Jul 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
fda-approval is the sole category represented across all 1 tracked stories. Department of the Interior is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Kristen Boyles, all published on July 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kristen Boyles. Shared-story counts are live from our verified record — not editorial picks.
The Trump administration’s rollback of Endangered Species Act protections could accelerate habitat loss for over 1,600 listed species, raising concerns in the biotech sector about the loss of undiscovered natural compounds critical for drug development.
Source: redmond-reporter.com · bothell-reporter.com
Kristen Boyles is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
